Free tool
FAERS Monitor: Prevantics Swabstick
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021524 or its brand name (Prevantics Swabstick, Chlorhexidine Gluconate, Isopropyl Alcohol). Reports on generic versions are filed under their own applications.
Reports
23
Serious
20
87% of reports
Hospitalization
18
Death reported
11
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- hand deformity16
- helicobacter infection16
- rheumatoid arthritis16
- swelling16
- systemic lupus erythematosus16
- glossodynia15
- infusion related reaction15
- joint swelling15
- synovitis15
- wound15
- rash14
- duodenal ulcer perforation13
- hepatic enzyme increased13
- hypersensitivity13
- impaired healing13
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 8 |
| 2025 | 1 |
| 2026 | 2 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,136 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| duodenal ulcer perforationSignal | 13 | 1601.4 | 1118.2 | 19,196 |
| helicobacter infectionSignal | 16 | 1425.6 | 1087.2 | 21,352 |
| hand deformitySignal | 16 | 1116.8 | 851.8 | 16,729 |
| synovitisSignal | 15 | 761.4 | 564.7 | 10,643 |
| glossodyniaSignal | 15 | 613.2 | 454.8 | 8,569 |
| woundSignal | 15 | 491.0 | 364.2 | 6,859 |
| systemic lupus erythematosusSignal | 16 | 412.4 | 314.7 | 6,169 |
| impaired healingSignal | 13 | 362.3 | 253.1 | 4,334 |
| infusion related reactionSignal | 15 | 207.0 | 153.6 | 2,881 |
| hepatic enzyme increasedSignal | 13 | 174.4 | 121.9 | 2,078 |
| swellingSignal | 16 | 156.4 | 119.3 | 2,327 |
| rheumatoid arthritisSignal | 16 | 128.9 | 98.4 | 1,915 |
| joint swellingSignal | 15 | 113.7 | 84.3 | 1,573 |
| hypersensitivitySignal | 13 | 64.0 | 44.8 | 752 |
| rashSignal | 14 | 29.4 | 21.2 | 363 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.